Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a Ki value of 6 nM and an EC90 value of 40 nM[1]. Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease[2]. Narlaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.3 µM[3].
Molecular Weight:
707.96
Purity:
98.15
CAS Number:
[865466-24-6]
Formula:
C36H61N5O7S
Target:
HCV,HCV Protease,SARS-CoV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
